Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
J. Brindha, Balamurali MM, Kaushik Chanda
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Synthesis and computational studies of 1,3,4-thiadiazole and benzothiazole clubbed benzimidazole analogous as anti-tubercular and anti-protozoal agent
Vatsal M. Patel, Navin B. Patel, Manuel J. Chan-Bacab, et al.
Journal of Molecular Structure (2025) Vol. 1319, pp. 139326-139326
Closed Access | Times Cited: 4
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Violeta Kourbeli, Eleni Chontzopoulou, Kalliopi Moschovou, et al.
Molecules (2021) Vol. 26, Iss. 15, pp. 4629-4629
Open Access | Times Cited: 66
Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host
Ranjeet Singh, Mohammad Kashif, Prateek Srivastava, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 706-706
Open Access | Times Cited: 29
Biosynthesis of ergosterol as a relevant molecular target of metal-based antiparasitic and antifungal compounds
Gonzalo Scalese, María Florencia Mosquillo, Leticia Pérez‐Díaz, et al.
Coordination Chemistry Reviews (2024) Vol. 503, pp. 215608-215608
Closed Access | Times Cited: 9
Antileishmanial Drug Discovery and Development: Time to Reset the Model?
Ana Isabel Olías-Molero, Concepción de la Fuente, Montserrat Cuquerella, et al.
Microorganisms (2021) Vol. 9, Iss. 12, pp. 2500-2500
Open Access | Times Cited: 56
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection
Greta Volpedo, Ryan H. Huston, Erin A. Holcomb, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 11, pp. 1431-1446
Open Access | Times Cited: 47
Current leishmaniasis drug discovery
Alessandra C. Pinheiro, M.V.N. De Souza
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 9, pp. 1029-1043
Open Access | Times Cited: 36
Leishmania vaccine development: A comprehensive review
Isha Saini, Jyoti Joshi, Sukhbir Kaur
Cellular Immunology (2024) Vol. 399-400, pp. 104826-104826
Closed Access | Times Cited: 8
Current and emerging therapies for the treatment of leishmaniasis
Shyam Sundar, Jitendra Singh, Vishal Singh, et al.
Expert Opinion on Orphan Drugs (2024) Vol. 12, Iss. 1, pp. 19-32
Open Access | Times Cited: 7
Facing diseases caused by trypanosomatid parasites: rational design of multifunctional oxidovanadium(IV) complexes with bioactive ligands
Gonzalo Scalese, Ignacio Machado, Fabiana Salazar, et al.
Frontiers in Chemical Biology (2024) Vol. 2
Open Access | Times Cited: 6
Synthesis of 4-(4-chlorophenyl)thiazole compounds: in silico and in vitro evaluations as leishmanicidal and trypanocidal agents
Iranildo José da Cruz Filho, Jamerson Ferreira de Oliveira, Aline Caroline da Silva Santos, et al.
Anais da Academia Brasileira de Ciências (2023) Vol. 95, Iss. 1
Open Access | Times Cited: 15
The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
Hayelom Berhe Dagnaw, Mahesh Kumar Cinthakunta Sridhar, Mulate Zerihun, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 227-227
Open Access | Times Cited: 5
Antifungal and Antiparasitic Activities of Metallocene-Containing Fluconazole Derivatives
Yan Lin, Gonzalo Scalese, Christina A. Bulman, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 3, pp. 938-950
Closed Access | Times Cited: 5
Facing Diseases Caused by Trypanosomatid Parasites: Rational Design of Pd and Pt Complexes With Bioactive Ligands
Dinorah Gambino, Lucı́a Otero
Frontiers in Chemistry (2022) Vol. 9
Open Access | Times Cited: 20
Synthesis, properties and mechanism of carbon dots-based nano-antibacterial materials
Haimei Zhu, Nannan Peng, Xiao Liang, et al.
Biomedical Materials (2023) Vol. 18, Iss. 6, pp. 062002-062002
Closed Access | Times Cited: 12
Natural-Product-Inspired Microwave-Assisted Synthesis of Novel Spirooxindoles as Antileishmanial Agents: Synthesis, Stereochemical Assignment, Bioevaluation, SAR, and Molecular Docking Studies
Nawal Kishore Sahu, Ritu Sharma, Kshirsagar Prasad Suhas, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4817-4817
Open Access | Times Cited: 11
Metallomics: An Essential Tool for the Study of Potential Antiparasitic Metallodrugs
Ignacio Machado, Dinorah Gambino
ACS Omega (2024) Vol. 9, Iss. 14, pp. 15744-15752
Open Access | Times Cited: 4
Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis
Olga Kammona, Evgenia Tsanaktsidou
International Journal of Pharmaceutics (2021) Vol. 605, pp. 120761-120761
Closed Access | Times Cited: 24
Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential
Sajad Rashidi, Celia Fernández-Rubio, Reza Mansouri, et al.
Parasitology Research (2022) Vol. 121, Iss. 1, pp. 49-62
Open Access | Times Cited: 17
Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: a patent review from 1998 to 2021
Mohd Imran, Shah Alam Khan, Abida Khan, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 5, pp. 591-604
Closed Access | Times Cited: 17
Leishmaniasis y su Resistencia a Fármacos: Un Enfoque Bibliométrico
César Aníbal Barzola Gaibor
Estudios y Perspectivas Revista Científica y Académica (2025) Vol. 4, Iss. 4, pp. 2464-2512
Closed Access
In vitro and in vivo leishmanicidal and trypanocidal activities of isoflavans from Tabebuia chrysantha (Jacq.) G. Nicholson timber by-products
Edwin Correa, Sara M. Robledo, Fernando Echeverri, et al.
Experimental Parasitology (2025), pp. 108899-108899
Open Access
Expression, Characterization and Selective Chemical Inhibition of Essential Schistosoma mansoni Tegumental Acetylcholinesterase (SmTAChE)
Patrick J. Skelly, Akram A. Da’dara
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1975-1975
Open Access
Antiparasitic, antioxidant and toxicological activities of methanolic extract from the inner mesocarp of Caryocar coriaceum Wittm. (Caryocaraceae)
José Thyálisson da Costa Silva, Saulo Almeida de Menezes, Magaly Lima Mota, et al.
Pharmacological Research - Natural Products (2025), pp. 100196-100196
Closed Access
Targeting Cysteine Protease B to Discover Antileishmanial Drugs: Directions and Advances
Esteban F. Rios, Sonaly Lima Albino, Ricardo Olímpio de Moura, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117500-117500
Closed Access
Page 1 - Next Page

Scroll to top